Neumora Therapeutics Inc.’s shares plummeted after the company’s experimental drug failed to show a benefit in a final-stage ...

Neuroscience company Neumora Therapeutics (NMRA) announced today that its experimental treatment for depression, Navacaprant, ...

Key Takeaways Neumora Therapeutics reported its experimental depression drug didn't meet expectations, and shares plunged.The ...

The well-funded biotech lost most of its value after its drug flunked a late-stage trial. One analyst described the results ...

Ketamine, a hallucinogenic drug approved as an anesthetic, has been used to treat adults with depression, PTSD and other conditions, and studied in youth with depression.

The history of weight loss medicines reads like a Greek tragedy. However, the biology behind the new GLP-1 agonists suggests ...

Studies show psilocybin from mushrooms could revolutionize depression treatment offering hope to millions who don't respond to traditional medications.

Those on the extreme end of the depression spectrum face symptoms that impact their daily activities too and not just their ...

It is the first drug to have an impact on the symptoms of manic depression since the introduction of lithium more than 50 years ago. In international trials over the past two years, daily doses of ...

Vagus nerve stimulation therapy improved the symptoms of treatment-resistant depression for nearly 500 participants in a ...

Doctors should think twice before prescribing drug therapies when faced with someone battling depression, as exercise may be more effective, according to a new study. A meta-analysis of 218 ...